McKesson Corporation: Expanding Healthcare Distribution With THESE High-Octane Growth Levers!

McKesson Corporation’s first-quarter fiscal 2026 performance reflects strong operational and financial results. This period was marked by significant revenue growth, strategic acquisitions, and effective capital management. The company reported consolidated revenues of $97.8 billion, indicating a 23% increase from the previous year, largely driven by increased prescription volumes from retail national account customers and the addition of new strategic accounts. Adjusted operating profit grew by 9% to $1.4 billion, with three segments showing double-digit growth in operating profit, underscoring momentum across McKesson’s operations.